We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Parithosh K. Tungaturthi, Ph.D.

Seyfarth Shaw LLP

Results 1 to 3 of 3
Most popular |Most recent

Teva Sues FDA Alleging Unlawful Interpretation of the Definition of “First Applicant”

USA - October 24 2018 The FDA Reauthorization Act of 2017 (FDARA) created a new type of 180-day exclusivity for ANDA applicants applying for approval of certain drugs...

Dean L. Fanelli.

USPTO Director Proposes New Patent Eligibility Guidance

USA - October 15 2018 The test for patentable subject matter under Section 101 lies at the heart of patent system. However, very little guidance is provided in the actual...

Innovation in Hatch-Waxman and ANDA Litigation

USA - March 12 2018 The Hatch-Waxman Act was enacted in 1984 to address two main congressional goals: (1) to encourage innovation in pharmaceutical research and...